Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate-Specific Antigen”

325 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 325 results

Testing effectiveness (Phase 2)Ended earlyNCT02420652
What this trial is testing

Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy

Who this might be right for
Recurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
Rutgers, The State University of New Jersey 27
Testing effectiveness (Phase 2)Study completedNCT00831792
What this trial is testing

TKI258 in Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 46
Post-approval studies (Phase 4)Ended earlyNCT00629330
What this trial is testing

Dissemination of Prostate Cancer Screening to PCP's in African American Communities

Who this might be right for
Prostate Cancer
Columbia University 86
Not applicableUnknownNCT05533047
What this trial is testing

Serum Prostatic Specific Antigen Changes After Bipolar and Monopolar TURP

Who this might be right for
PSA Changes After TURP
Assiut University 2
Not applicableStudy completedNCT01684358
What this trial is testing

A Trial on the Effect of Sino-implant (II) Use on Condom Use Among Women in Kingston, Jamaica

Who this might be right for
Women Wanting Contraceptive Implant for Pregnancy Prevention
Centers for Disease Control and Prevention 414
Testing effectiveness (Phase 2)Study completedNCT01046916
What this trial is testing

Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 38
Early research (Phase 1)Study completedNCT05441501
What this trial is testing

JNJ-80038114 in Participants With Advanced Stage Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 39
Early research (Phase 1)Study completedNCT06641219
What this trial is testing

Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate-Specific Membrane Antigen

Who this might be right for
Prostate Cancers
Tomsk National Research Medical Center of the Russian Academy of Sciences 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05896371
What this trial is testing

Personalized PSMA Radiopharmaceutical Therapy

Who this might be right for
CancerProstate CancerMetastatic Cancer+1 more
CHU de Quebec-Universite Laval 500
Not applicableNot Yet RecruitingNCT06608225
What this trial is testing

Prognostic Study of Prostate Cancer Via Dynamic Change of PSA in Peritoneal Drainage Fluid After Radical Prostatectomy

Who this might be right for
Prostatic NeoplasmsProstate-Specific Antigen
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)UnknownNCT00731848
What this trial is testing

Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Roll International Corporation 30
Early research (Phase 1)Looking for participantsNCT07082920
What this trial is testing

JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 140
Testing effectiveness (Phase 2)Study completedNCT00109811
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Ended earlyNCT00450008
What this trial is testing

Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 9
Not applicableStudy completedNCT05819606
What this trial is testing

Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 70
Testing effectiveness (Phase 2)Ended earlyNCT01681433
What this trial is testing

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

Who this might be right for
Prostate CancerMetastatic Castrate-Resistant Prostate CancerPSA
Costantine Albany 72
Testing effectiveness (Phase 2)WithdrawnNCT00681148
What this trial is testing

Botulinum Toxin Injection With Prostate Brachytherapy

Who this might be right for
Prostate CancerLower Urinary Tract SymptomsRadioactive Seed Implantation
Emory University
Not applicableLooking for participantsNCT06209853
What this trial is testing

Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer Patient

Who this might be right for
Prostatic Neoplasms
Assiut University 59
Not applicableUnknownNCT05995236
What this trial is testing

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Who this might be right for
Prostate Cancer
Methodist Health System 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT05478239
What this trial is testing

ArtemiCoffee in Patients With Rising PSA

Who this might be right for
Prostate Cancer
Zin W Myint 20
Load More Results